Document is current
Any future updates will be listed below
-
Authors
Ilumäe, Anne-Mai https://orcid.org/0000-0001-6920-1335
Post, Helen
Flores, Rodrigo https://orcid.org/0000-0002-0965-5973
Karmin, Monika https://orcid.org/0000-0001-9827-5579
Sahakyan, Hovhannes https://orcid.org/0000-0003-1596-2838
Mondal, Mayukh
Montinaro, Francesco
Saag, Lauri
Bormans, Concetta
Sanchez, Luisa Fernanda
Ameur, Adam https://orcid.org/0000-0001-6085-6749
Gyllensten, Ulf
Kals, Mart
Mägi, Reedik
Pagani, Luca https://orcid.org/0000-0002-6639-524X
Behar, Doron M.
Rootsi, Siiri
Villems, Richard
-
Funding
Funding for this research was provided by:
Eesti Teadusagentuur (PRG243, PRG243, PRG243, PRG1071, PRG243, PRG1071)
Suomalainen Tiedeakatemia (329257)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (3UM1HG008901-03S1)
Haridus- ja Teadusministeerium (IUT24-1)
EC | European Regional Development Fund (2014-2020.4.01.16-0024 (MOBTT53), 2014-2020.4.01.16-0024 (MOBTT53))
- License Information
-
More Information
Article History
Received: 19 January 2021
Accepted: 13 April 2021
First Online: 7 May 2021
Compliance with ethical standards
:
: DMB and CB declare stock ownership at Gene by Gene, Ltd. LFS in an employee of Gene by Gene.
: All donors have provided informed consent and all experiments were performed in accordance with the relevant guidelines and regulations of collaborating institutions. Access to genetic data in Estonian Biobank was approved by the Research Ethics Committee of the University of Tartu (permission number 1.1.-12/659 granted by the Research Ethics Committee of the University of Tartu, Estonia). The chrY sequences included from customers of the commercial personal genetic testing service were only from individuals who had provided informed consent for the use of their data in scientific research and for publication in aggregated form. The list of IDs along with additional sample information is presented in Supplementary Table .
